ArticleFrontiers in psychiatry2026
Altered EEG microstate associated with anxiety and somatization symptoms in major depressive disorder.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To examine abnormalities in EEG microstate dynamics in patients with major depressive disorder (MDD) and to explore their associations with anxiety and somatization symptoms. Methods: We enrolled 30 patients with MDD and 40 healthy controls. Resting-state EEG was recorded and analyzed using microstate segmentation (classes A-D). Temporal parameters (mean duration, occurrence, time coverage, and transition probabilities) were compared between groups, and correlations with clinical symptoms (HAMD, HAMA, MADRS) were examined. Results: Compared with controls, patients with MDD exhibited a significantly longer duration, higher occurrence, and greater time coverage of microstate C, while microstate B showed reduced occurrence and coverage. Transition probability analyses revealed fewer transitions from A to B, A to D, B to A, B to D, and D to A, and more transitions between C and D. Symptom correlations indicated that microstate B occurrence was positively associated with HAMD anxiety/somatization scores, while transitions from C to D and from D to C were negatively correlated with anxiety/somatization scores. Conclusions: MDD is characterized by alterations in microstate B and C dynamics and disrupted transitions between C and D, some of which relate to symptom dimensions, suggesting that EEG microstate features may serve as potential neurophysiological markers in major depressive disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.